Christophe Ferrand

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 14

Top Venues

International journal of molecular sciences

Science signaling

Gene therapy

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Lucie Bouquet, Elodie Bôle-Richard, Walid Warda, Mathieu Neto Da Rocha, Rim Trad, Clémentine Nicod, Rafik Haderbache, Delphine Genin, Christophe Ferrand, Marina Deschamps
RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells. Gene therapy (2023)
Rim Trad, Walid Warda, Vincent Alcazer, Mathieu Neto da Rocha, Ana Berceanu, Clémentine Nicod, Rafik Haderbache, Xavier Roussel, Yohan Desbrosses, Etienne Daguindau, Florain Renosi, Christophe Roumier, Lucie Bouquet, Sabeha Biichle, Melanie Guiot, Evan Seffar, Denis Caillot, Stephane Depil, Eric Robinet, Yahya Salma, Eric Deconinck, Marina Deschamps, Christophe Ferrand
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia. Journal for immunotherapy of cancer 10 (7) (2022)
Jame Frenay, Pierre-Simon Bellaye, Alexandra Oudot, Alex Helbling, Camille Petitot, Christophe Ferrand, Bertrand Collin, Alexandre M M Dias
IL-1RAP, a Key Therapeutic Target in Cancer. International journal of molecular sciences 23 (23) (2022)
Mathieu Neto Da Rocha, Melanie Guiot, Clementine Nicod, Rim Trad, Lucie Bouquet, Rafik Haderbache, Walid Warda, Pierre-Emmanuel Baurand, Chloe Jouanneau, Philippe Dulieu, Marina Deschamps, Christophe Ferrand
Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro. Immunologic research (2022)
Jame Frenay, Pierre-Simon Bellaye, Alexandra Oudot, Alex Helbling, Camille Petitot, Christophe Ferrand, Bertrand Collin, Alexandre M M Dias
IL-1RAP, a Key Therapeutic Target in Cancer. International journal of molecular sciences 23 (23) (2022)
Jame Frenay, Pierre-Simon Bellaye, Alexandra Oudot, Alex Helbling, Camille Petitot, Christophe Ferrand, Bertrand Collin, Alexandre M M Dias
IL-1RAP, a Key Therapeutic Target in Cancer. International journal of molecular sciences 23 (23) (2022)
Jame Frenay, Pierre-Simon Bellaye, Alexandra Oudot, Alex Helbling, Camille Petitot, Christophe Ferrand, Bertrand Collin, Alexandre M M Dias
IL-1RAP, a Key Therapeutic Target in Cancer. International journal of molecular sciences 23 (23) (2022)
Rafik Haderbache, Walid Warda, Eric Hervouet, Mathieu Neto da Rocha, Rim Trad, Vincent Allain, Clementine Nicod, Catherine Thieblemeont, Nicolas Boissel, Pauline Varlet, Ibrahim Yakoub Agha, Lucie Bouquet, Melanie Guiot, Fabienne Venet, Pierre Sujobert, Xavier Roussel, Paul-Oliver Rouzaire, Denis Caillot, Olivier Casasnovas, Jean Christophe Bories, Emmanuel Bachy, Sophie Caillat-Zucman, Marina Deschamps, Christophe Ferrand
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients. Journal of translational medicine 19 (1) (2021)
Walid Warda, Mathieu Neto Da Rocha, Rim Trad, Rafik Haderbache, Yahya Salma, Lucie Bouquet, Xavier Roussel, Clémentine Nicod, Marina Deschamps, Christophe Ferrand
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch. Cancer gene therapy 28 (12) (2021)
Elodie Bôle-Richard, Maxime Fredon, Sabeha Biichlé, François Anna, Jean-Marie Certoux, Florian Renosi, Frédéric Tsé, Chloé Molimard, Séverine Valmary-Degano, Alizée Jenvrin, Walid Warda, Jean-René Pallandre, Francis Bonnefoy, Margaux Poussard, Marina Deschamps, Tony Petrella, Christophe Roumier, Elizabeth Macintyre, Frédéric Féger, Eolia Brissot, Mohamad Mohty, Kiave-Yune HoWangYin, Pierre Langlade-Demoyen, Maria Loustau, Julien Caumartin, Yann Godet, Delphine Binda, Maïder Pagadoy, Eric Deconinck, Etienne Daguindau, Philippe Saas, Christophe Ferrand, Fanny Angelot-Delettre, Olivier Adotévi, Francine Garnache-Ottou
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm. Leukemia 34 (12) (2020)
Claire Gorby, Junel Sotolongo Bellón, Stephan Wilmes, Walid Warda, Elizabeth Pohler, Paul K Fyfe, Adeline Cozzani, Christophe Ferrand, Mark R Walter, Suman Mitra, Jacob Piehler, Ignacio Moraga
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Science signaling 13 (649) (2020)
Camille Lachat, Diane Bruyère, Amandine Etcheverry, Marc Aubry, Jean Mosser, Walid Warda, Michaël Herfs, Elodie Hendrick, Christophe Ferrand, Christophe Borg, Régis Delage-Mourroux, Jean-Paul Feugeas, Michaël Guittaut, Eric Hervouet, Paul Peixoto
EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas. Cancers 12 (12) (2020)
Julien Magne, Alizée Jenvrin, Adrien Chauchet, Olivier Casasnovas, Anne Donzel, Laurence Jego, Bernard Aral, Julien Guy, Nathalie Nadal, Dewi Vernerey, Patrick Callier, Francine Garnache-Ottou, Christophe Ferrand
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies. Experimental hematology & oncology 7 (2018)
Romain Loyon, Emilie Picard, Olivier Mauvais, Lise Queiroz, Virginie Mougey, Jean-René Pallandre, Jeanne Galaine, Patricia Mercier-Letondal, Guillaume Kellerman, Nathalie Chaput, John Wijdenes, Olivier Adotévi, Christophe Ferrand, Pedro Romero, Yann Godet, Christophe Borg
IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. Journal of immunology (Baltimore, Md. : 1950) 197 (1) (2016)

Christophe Ferrand.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christophe Ferrand